SPDR S&P Biotech ETF (NYSEARCA:XBI) Stock Position Lessened by Ted Buchan & Co

Ted Buchan & Co decreased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.6% during the third quarter, Holdings Channel reports. The firm owned 90,208 shares of the exchange traded fund’s stock after selling 5,322 shares during the quarter. SPDR S&P Biotech ETF comprises about 4.2% of Ted Buchan & Co’s holdings, making the stock its 8th biggest position. Ted Buchan & Co’s holdings in SPDR S&P Biotech ETF were worth $8,913,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in XBI. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of SPDR S&P Biotech ETF by 30.3% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after acquiring an additional 730,000 shares during the period. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of SPDR S&P Biotech ETF by 1.6% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock worth $106,158,000 after buying an additional 18,202 shares during the last quarter. Jane Street Group LLC grew its position in SPDR S&P Biotech ETF by 68.7% during the first quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock valued at $91,197,000 after buying an additional 391,333 shares during the period. Bessemer Group Inc. increased its holdings in SPDR S&P Biotech ETF by 1.7% during the first quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock valued at $87,572,000 after buying an additional 15,794 shares during the last quarter. Finally, Employees Retirement System of Texas grew its position in shares of SPDR S&P Biotech ETF by 40.8% during the 2nd quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock valued at $55,984,000 after acquiring an additional 174,857 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $104.18 on Friday. The stock’s fifty day moving average is $98.96 and its 200 day moving average is $95.60. SPDR S&P Biotech ETF has a one year low of $64.99 and a one year high of $104.22. The stock has a market cap of $7.94 billion, a P/E ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.